Get in touch
© 2014-2024 Hospitality Medservice. All rights reserved.
Get in touch

PSMA PET-CT

I accept Terms and Conditions and agree to receive marketing letters that can be interesting for me.

Prostate-specific membrane antigen (PSMA) PET-CT is currently the most effective method for diagnosing metastases in prostate cancer.

PSMA PET-CT has high sensitivity, allowing for the early detection of recurrence even in the absence of elevated PSA levels in blood tests.

Indications for use:

  • Determining the stage of prostate cancer
  • Assessing the effectiveness of treatment

Features of the procedure in global clinics

The patient receives an 18F-PSMA-1007 radiopharmaceutical (fluorodeoxyglucose – an analog of natural glucose), which accumulates in tumor cells. As a result, atypical structures become visible on the PET-CT scan, allowing doctors to see tumor spread and metastasis.

Unlike other diagnostic methods, PSMA PET-CT can detect extremely small cancerous lesions and is effective even when PSMA levels are as low as 0.2. The possibility of detecting recurrence at this low prostate-specific membrane antigen level is 60%, making it one of the most accurate and advanced diagnostic tools available today.